Ontology highlight
ABSTRACT: Aim of the study
Despite achieving a high cure rate of chronic hepatitis C nowadays, treatment failure remains a major concern and host genetic polymorphism could have a possible relation. The aim was to evaluate the role of chemokine receptor CXCR6 gene polymorphism in treatment response to direct acting antivirals (DAAs) in chronic hepatitis C virus (HCV) patients.Material and methods
We investigated the chemokine receptor CXCR6 gene single nucleotide polymorphism rs2234358 in three groups. Responder and non-responder groups (each comprising 50 naïve patients) and a control group of 50 apparently healthy individuals were studied.Results
Genotype distribution revealed a significant difference (p = 0.037) between non-responders and the other 2 groups. Both co
SUBMITTER: Hassona MM
PROVIDER: S-EPMC8977876 | biostudies-literature | 2021 Dec
REPOSITORIES: biostudies-literature